We collected information about Stoke Therapeutics Inc Hours for you. Follow the liks to find out everything about Stoke Therapeutics Inc Hours.
https://www.stoketherapeutics.com/
Stoke Therapeutics Presents Data from the Phase 1/2a MONARCH Study of STK-001 in Children and Adolescents with Dravet Syndrome at the American Epilepsy Society (AES) 2021 Annual Meeting. December 3, 2021. Read more.
https://www.nasdaq.com/market-activity/stocks/stok/after-hours
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET).
https://www.stoketherapeutics.com/contact-us/
https://www.nasdaq.com/market-activity/stocks/stok
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET).
https://www.barrons.com/market-data/stocks/stok
Complete Stoke Therapeutics Inc. stock information by Barron's. View real-time STOK stock price and news, along with industry-best analysis. …
https://www.marketwatch.com/investing/stock/stok/company-profile
Stoke Therapeutics Inc. 45 Wiggins Avenue. Bedford, Massachusetts 01730. Phone 1 781 430-8200. Industry Biotechnology. Sector Health Care/Life Sciences.
https://www.benzinga.com/general/biotech/21/12/24434391/stoke-touts-early-signs-of-efficacy-for-antisense-drug-in-dravet-syndrome
2 days ago · Stoke Therapeutics Inc (NASDAQ: STOK) announced highlights from five presentations related to the ongoing clinical development of STK-001 being made at …
https://newsheater.com/2021/12/03/the-chart-for-stoke-therapeutics-inc-stok-is-flashing-mixed-signals/
Stoke Therapeutics Inc. (NASDAQ:STOK) went down by -1.30% from its latest closing price compared to the recent 1-year high of $71.58. The company’s stock price has collected -13.71% of loss in the last five trading sessions. Press Release reported 36 min ago that Stoke Therapeutics Presents Data from the Phase 1/2a MONARCH Study of STK-001 in Children and Adolescents with …
https://investor.stoketherapeutics.com/
Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines. Using the company’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach Stoke is developing antisense oligonucleotides (ASOs) to ...
Searching for Stoke Therapeutics Inc Hours?
You can just click the links above. The info is collected for you.
